StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > From IR last week

<< Previous

Bullboard Posts

Next >>

Comment by IainCaimbeulon Sep 26, 2024 9:11pm

42 Views

Post# 36243349

RE:From IR last week

"Likely for maintenance" - seriously for maintenance, NO likely for sheer incompetance. She did not know the website was down until I posted it on stockhouse and the little sycophant known as nb1/2 informed her, beyond wierd.

LithLover wrote: From Nails on CEO last week.

---------------------------------------------- I will have a look. Likely for maintenance as we are busy behind the scenes working. Q2 will be filed shortly and then there will be additional announcements. Thank you for the heads up. I will follow up with IT. Cheers Rebecca Rebecca Greco Head of Investor Relations

----------------------

The website is back up Check
Q2 was filed Check
Let's see if the 3rd item holds true and some announcements are forthcoming.